Agenus (AGEN) Enterprise Value (2010 - 2026)
Agenus (AGEN) posted quarterly Enterprise Value of -$41.8 million for Q1 2026, down 4440.75% year-over-year from $962000.0 in Q1 2025, and down 328.38% quarter-over-quarter from -$9.7 million in Q4 2025.
Agenus (AGEN) Enterprise Value (2010 - 2026) Analysis & Trends
Agenus' Enterprise Value history runs 17 years deep, the most recent figure standing at -$41.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 4440.75% year-over-year to -$41.8 million; the TTM figure through Mar 2026 stood at -$41.8 million (down 4440.75% YoY), while the FY2025 annual figure was -$9.7 million, up 52.4% from the prior year.
- Enterprise Value for Q1 2026 stood at -$41.8 million, down from -$9.7 million in the prior quarter.
- The five-year high for Enterprise Value was $8.8 million in Q2 2025, with the low at -$250.8 million in Q1 2022.
- The 5-year median for Enterprise Value is -$64.2 million (2023), against an average of -$92.3 million.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value surged 111.96% in 2025, then plunged 4440.75% in 2026.
- Agenus' Enterprise Value stood at -$187.0 million in 2022, then surged by 65.69% to -$64.2 million in 2023, then surged by 68.08% to -$20.5 million in 2024, then jumped by 52.4% to -$9.7 million in 2025, then slumped by 328.38% to -$41.8 million in 2026.
- Business Quant data shows AGEN's Enterprise Value at -$41.8 million in Q1 2026, -$9.7 million in Q4 2025, and -$10.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | -25.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.51 Mn |
| Mar 31, 2026 | -41.76 Mn |
| Dec 31, 2025 | -9.75 Mn |
| Sep 30, 2025 | -10.19 Mn |
| Jun 30, 2025 | 8.76 Mn |
| Mar 31, 2025 | 962,000.00 |
| Dec 31, 2024 | -20.48 Mn |
| Sep 30, 2024 | -24.25 Mn |
| Jun 30, 2024 | -73.25 Mn |
| Mar 31, 2024 | -41.75 Mn |
| Dec 31, 2023 | -64.16 Mn |
| Sep 30, 2023 | -92.49 Mn |
| Jun 30, 2023 | -141.42 Mn |
| Mar 31, 2023 | -183.81 Mn |
| Dec 31, 2022 | -186.98 Mn |
| Sep 30, 2022 | -209.68 Mn |
| Jun 30, 2022 | -228.11 Mn |
| Mar 31, 2022 | -250.76 Mn |
| Dec 31, 2021 | -293.45 Mn |
| Sep 30, 2021 | -267.83 Mn |